Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC15A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WFDC21P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CXCL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MVP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISG20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPSTI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR5193 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on